更新于：2024-11-04
Garenoxacin Mesilate Hydrate
甲磺酸加诺沙星
更新于：2024-11-04
概要
基本信息
药物类型 小分子化药 |
别名 Des-F(6)-quinolone、Desquinolone、Garenoxacin + [14] |
作用机制 细菌DNA旋转酶复合体抑制剂、拓扑异构酶 IV抑制剂 |
非在研适应症 |
非在研机构 |
最高研发阶段批准上市 |
最高研发阶段(中国)批准上市 |
特殊审评- |
登录后查看时间轴
结构
分子式C24H26F2N2O8S |
InChIKeyIGTHEWGRXUAFKF-NVJADKKVSA-N |
CAS号223652-90-2 |
关联
16
项与 甲磺酸加诺沙星 相关的临床试验甲磺酸加诺沙星片在中国健康受试者中空腹/餐后口服给药的单中心、开放、随机、两序列、两周期交叉生物等效性试验
Clinical efficacy of garenoxacin for treatment of bacterial respiratory infection secondary to chronic respiratory disease - GARIREO study
Specific post-marketing surveillance of garenoxacin (Geninax) Clinical efficacy and safety of garenoxacin in the treatment of legionella pneumonia
100 项与 甲磺酸加诺沙星 相关的临床结果
登录后查看更多信息
100 项与 甲磺酸加诺沙星 相关的转化医学
登录后查看更多信息
100 项与 甲磺酸加诺沙星 相关的专利（医药）
登录后查看更多信息
297
项与 甲磺酸加诺沙星 相关的文献（医药）2024-08-06ENVIRONMENTAL SCIENCE & TECHNOLOGY
Solar Photodegradation of a Novel des-F(6)-Fluoroquinolone, Garenoxacin, and Ecotoxicity of Its Phototransformation Products
Article
作者: Huang, Shengnan ; Cheng, Hefa ; Lin, Chunye ; Zhang, Zhaobin
Garenoxacin (GRNX) is a novel des-F(6)-fluoroquinolone on the horizon; thus, its fate and risk in the aquatic environment deserve attention. This study systematically investigated, for the first time, the phototransformation of GRNX under simulated and natural sunlight and assessed the ecotoxicity of its photodegradation products. Phototransformation of GRNX was observed to depend strongly on its ionization state, with direct photolysis and self-sensitized photolysis having comparable contributions for the cationic and zwitterionic species, while the latter dominated for the anionic species. Singlet oxygen generated via the self-sensitized photolysis of GRNX was the major reactive oxygen species in its photodegradation. Phototransformation of GRNX in different ionization states followed distinct pathways, with defluorination of the difluoromethyl group occurring only for the zwitterionic and anionic species. GRNX photodegradation in natural water could be described by a simple kinetic model based on the measured steady-state concentrations of 1O2 and ·OH. Toxicity tests with Vibrio fischeri and Chlorella vulgaris consistently indicate that the generation of hydroxylation and decarboxylation products during photodegradation of GRNX increased the acute toxicity. These findings not only provide insights into the fate of GRNX in sunlit surface water but also reveal the potentially significant risk of its photodegradation products to the aquatic ecosystem.
2024-02-01European journal of dermatology : EJD
Fixed drug eruption due to tipepidine hibenzate and garenoxacin mesylate hydrate: an unusual case of polysensitivity
Article
作者: Fukuda, Hidetsugu ; Harada, Yuya
2023-11-10Cureus
Fixed Drug Eruption Caused by Garenoxacin: A Case Report and Literature Review
作者: Sawada, Yu ; Hara, Natsumi ; Saito-Sasaki, Natsuko
A new quinolone antibiotic called garenoxacin was developed in Japan. Garenoxacin is known to produce cutaneous adverse effects, particularly fixed drug eruption in Japan, despite several reports of cutaneous adverse events in English-language literature. However, English-language literature has not yet reported that fixed drug eruption is a common clinical manifestation of garenoxacin-induced drug eruption. In this article, we present a case of multiple fixed drug eruptions and review the literature on case reports of drug eruptions caused by garenoxacin.
1
项与 甲磺酸加诺沙星 相关的新闻（医药）2024-09-20
·药闻康策
100 项与 甲磺酸加诺沙星 相关的药物交易
登录后查看更多信息
研发状态
批准上市
10 条最早获批的记录, 后查看更多信息
登录
| 适应症 | 国家/地区 | 公司 | 日期 |
|---|---|---|---|
| 大肠杆菌感染 | 日本 | 2023-07-31 | |
| 大肠杆菌感染 | 日本 | 2023-07-31 | |
| 克雷伯菌感染 | 日本 | 2023-07-31 | |
| 克雷伯菌感染 | 日本 | 2023-07-31 | |
| 支原体感染 | 日本 | 2023-07-31 | |
| 支原体感染 | 日本 | 2023-07-31 | |
| 中耳炎 | 日本 | 2023-07-31 | |
| 中耳炎 | 日本 | 2023-07-31 | |
| 咽喉炎 | 日本 | 2023-07-31 | |
| 咽喉炎 | 日本 | 2023-07-31 | |
| 肺炎球菌感染 | 日本 | 2023-07-31 | |
| 肺炎球菌感染 | 日本 | 2023-07-31 | |
| 细菌性肺炎 | 中国 | 2019-07-25 | |
| 呼吸道感染 | 中国 | 2019-07-12 | |
| 细菌感染 | 韩国 | 2009-09-01 | |
| 急性支气管炎 | 日本 | 2007-07-31 | |
| 喉炎 | 日本 | 2007-07-31 | |
| 肺炎 | 日本 | 2007-07-31 | |
| 慢性呼吸道感染 | 日本 | 2007-07-31 | |
| 鼻窦炎 | 日本 | 2007-07-31 |
未上市
10 条进展最快的记录, 后查看更多信息
登录
| 适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
|---|---|---|---|---|
| 慢性支气管炎 | 申请上市 | 欧盟 | - | |
| 社区获得性肺炎 | 申请上市 | 欧盟 | - | |
| 复杂的皮肤和软组织感染 | 申请上市 | 欧盟 | - | |
| 腹腔感染 | 申请上市 | 欧盟 | - |
登录后查看更多信息
临床结果
临床结果
适应症
分期
评价
查看全部结果
登录后查看更多信息
转化医学
使用我们的转化医学数据加速您的研究。
登录
或
药物交易
使用我们的药物交易数据加速您的研究。
登录
或
核心专利
使用我们的核心专利数据促进您的研究。
登录
或
临床分析
紧跟全球注册中心的最新临床试验。
登录
或
批准
利用最新的监管批准信息加速您的研究。
登录
或
特殊审评
只需点击几下即可了解关键药物信息。
登录
或
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。
生物序列数据库
生物药研发创新
免费使用
化学结构数据库
小分子化药研发创新
免费使用